These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 26490882

  • 21. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.
    Naik RP, Streiff MB, Lanzkron S.
    J Thromb Thrombolysis; 2013 Apr; 35(3):352-8. PubMed ID: 23435703
    [Abstract] [Full Text] [Related]

  • 22. COVID-19 and venous thromboembolism risk in patients with sickle cell disease.
    Singh A, Brandow AM, Wun T, Shet AS.
    Blood Adv; 2022 Aug 09; 6(15):4408-4412. PubMed ID: 35763429
    [Abstract] [Full Text] [Related]

  • 23. Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication.
    Naik RP, Streiff MB, Haywood C, Nelson JA, Lanzkron S.
    Am J Med; 2013 May 09; 126(5):443-9. PubMed ID: 23582935
    [Abstract] [Full Text] [Related]

  • 24. Venous thromboembolism in the Get With The Guidelines-Stroke acute ischemic stroke population: incidence and patterns of prophylaxis.
    Douds GL, Hellkamp AS, Olson DM, Fonarow GC, Smith EE, Schwamm LH, Cockroft KM.
    J Stroke Cerebrovasc Dis; 2014 Jan 09; 23(1):123-9. PubMed ID: 23253528
    [Abstract] [Full Text] [Related]

  • 25. Active tuberculosis and venous thromboembolism: association according to international classification of diseases, ninth revision hospital discharge diagnosis codes.
    Dentan C, Epaulard O, Seynaeve D, Genty C, Bosson JL.
    Clin Infect Dis; 2014 Feb 09; 58(4):495-501. PubMed ID: 24280089
    [Abstract] [Full Text] [Related]

  • 26. Evaluating the safety and effectiveness of venous thromboembolism prophylaxis in patients with sickle cell disease.
    Kelley D, Jones LT, Wu J, Bohm N.
    J Thromb Thrombolysis; 2017 May 09; 43(4):463-468. PubMed ID: 27943026
    [Abstract] [Full Text] [Related]

  • 27. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.
    Salami A, Qureshi W, Kuriakose P, Moonka D, Yoshida A, Abouljoud M.
    Transplant Proc; 2013 May 09; 45(1):315-9. PubMed ID: 23267811
    [Abstract] [Full Text] [Related]

  • 28. Hospital-associated venous thromboembolism in children: incidence and clinical characteristics.
    Takemoto CM, Sohi S, Desai K, Bharaj R, Khanna A, McFarland S, Klaus S, Irshad A, Goldenberg NA, Strouse JJ, Streiff MB.
    J Pediatr; 2014 Feb 09; 164(2):332-8. PubMed ID: 24332452
    [Abstract] [Full Text] [Related]

  • 29. Venous thromboembolism in COPD hospitalized patients.
    Barba R, Zapatero A, Marco J, Losa JE, Plaza S, Casas JM, Canora J.
    J Thromb Thrombolysis; 2012 Jan 09; 33(1):82-7. PubMed ID: 22016148
    [Abstract] [Full Text] [Related]

  • 30. When children become adults and adults become most hypercoagulable after trauma: An assessment of admission hypercoagulability by rapid thrombelastography and venous thromboembolic risk.
    Liras IN, Rahbar E, Harting MT, Holcomb JB, Cotton BA.
    J Trauma Acute Care Surg; 2016 May 09; 80(5):778-82. PubMed ID: 26886005
    [Abstract] [Full Text] [Related]

  • 31. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
    Holmqvist ME, Neovius M, Eriksson J, Mantel Ä, Wållberg-Jonsson S, Jacobsson LT, Askling J.
    JAMA; 2012 Oct 03; 308(13):1350-6. PubMed ID: 23032551
    [Abstract] [Full Text] [Related]

  • 32. Risk factors for venous thromboembolism in children.
    Gerotziafas GT.
    Int Angiol; 2004 Sep 03; 23(3):195-205. PubMed ID: 15765033
    [Abstract] [Full Text] [Related]

  • 33. How I diagnose and treat venous thromboembolism in sickle cell disease.
    Shet AS, Wun T.
    Blood; 2018 Oct 25; 132(17):1761-1769. PubMed ID: 29764840
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients.
    Okoye HC, Ezekekwu C, Nwagha TU, Korubo K, Omunakwe HE, Nnachi OC, Madu AJ, Nwogoh B, Efobi CC, Muoghalu EA, Nonyelu C, Okoye AE, Obodo OI, Ugwu CS, Egolum MC, Nnachi OA, Okpala I.
    Eur J Haematol; 2022 Oct 25; 109(4):321-326. PubMed ID: 35687045
    [Abstract] [Full Text] [Related]

  • 35. Venous thromboembolism in heart transplant recipients: incidence, recurrence and predisposing factors.
    Alvarez-Alvarez RJ, Barge-Caballero E, Chavez-Leal SA, Paniagua-Martin MJ, Marzoa-Rivas R, Caamaño CB, López-Sainz Á, Grille-Cancela Z, Blanco-Canosa P, Herrera-Noreña JM, Cuenca-Castillo JJ, Castro-Beiras A, Crespo-Leiro MG.
    J Heart Lung Transplant; 2015 Feb 25; 34(2):167-74. PubMed ID: 25434523
    [Abstract] [Full Text] [Related]

  • 36. Bloodstream infections in hospitalized adults with sickle cell disease: a retrospective analysis.
    Chulamokha L, Scholand SJ, Riggio JM, Ballas SK, Horn D, DeSimone JA.
    Am J Hematol; 2006 Oct 25; 81(10):723-8. PubMed ID: 16795063
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Association of hospital and provider types on sickle cell disease outcomes.
    Jan S, Slap G, Smith-Whitley K, Dai D, Keren R, Rubin DM.
    Pediatrics; 2013 Nov 25; 132(5):854-61. PubMed ID: 24167173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.